Stefan-Mikić Sandra, Sević Sinisa, Doder Radoslava, Cvjetković Dejan, Jovanović Natasa, Ruzić Maja
Klinika za infektivne bolesti, Klinicki centar Vojvodine, Novi Sad, Srbija.
Vojnosanit Pregl. 2012 Aug;69(8):647-55. doi: 10.2298/vsp1208647s.
BACKGROUND/AIM: The Serbian health system does not have strict guidelines for the treatment of bacterial infections. The choice of treatment is empirical which is not necessarily the same compared to the treatment guidelines from countries with a developed pharmacotherapeutic practice. In this study we compared the difference between the current treatment and the treatment taking into account the latest pharmacotherapeutic and pharmacoeconomic guidelines in order to estimate clinical efficiency of antibacterial drugs that were given as a therapy of urinary tract infections and to evaluate pharmacoeconomic aspect of this therapy as well.
Our study included 100 patients that were randomly chosen and divided into 2 groups. The first group was treated in an ordinary way, while the second one was treated strictly in accordance with the guidelines (British National Formulary - BNF, and Senford Guide). In both groups of the patients we compared length of hospitalization, combination of the used antibiotics, progress as a whole in clinical picture, laboratory analyses and the price of the whole treatment.
Analyzing these values independently and according to statistical tests we proved that there were no significant differences between two groups with regard to the progress in a clinical picture as a whole and the length of hospitalization. According to this analysis, however suggested treatment based on guidelines showed a saving of 34.48% in comparison with the usual system of therapy.
Efficacy of current treatment of urinary tract infection and the treatment according to foreign guidelines is the same, but the costs of the treatment are lower if the guidelines of developed health care systems are applied.
背景/目的:塞尔维亚医疗系统在细菌感染治疗方面没有严格的指导方针。治疗方案的选择是经验性的,与药物治疗实践发达的国家的治疗指南相比不一定相同。在本研究中,我们比较了当前治疗与参照最新药物治疗和药物经济学指南的治疗之间的差异,以评估作为尿路感染治疗药物的抗菌药物的临床疗效,并评估该治疗的药物经济学方面。
我们的研究纳入了100例随机选择的患者,并将其分为2组。第一组采用常规方式治疗,而第二组严格按照指南(英国国家处方集-BNF和森福德指南)进行治疗。在两组患者中,我们比较了住院时间、所用抗生素的组合、整体临床症状进展、实验室分析以及整个治疗的费用。
独立分析这些值并根据统计检验,我们证明两组在整体临床症状进展和住院时间方面没有显著差异。然而,根据该分析,与常规治疗系统相比,基于指南的建议治疗节省了34.48%。
当前尿路感染治疗与参照国外指南的治疗效果相同,但应用发达医疗保健系统的指南时治疗成本更低。